Alcidion Group Shareholders Approve 1-for-10 Capital Consolidation at AGM on 12 November 2026

Aditi Sarkar

12 November 2026 05:56 PM AEDT

Alcidion Group Shareholders Approve 1-for-10 Capital Consolidation at AGM on 12 November 2026

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Alcidion Group Limited (ASX:ALC) has announced that shareholders approved Resolution 3 'Consolidation of Capital' at the company's Annual General Meeting held on 12 November 2026, with the company to proceed with a 1-for-10 consolidation of its issued capital.

Key Points

Shareholders approved the 1-for-10 consolidation of Alcidion's issued capital at the AGM held on 12 November 2026.
The consolidation does not change Alcidion's market capitalisation, underlying value, assets, liabilities, cash position, strategy or operations.
Fractional entitlements to a share or performance right arising from the consolidation will be rounded up to the nearest whole number.
Normal trading in reorganised securities is scheduled to commence on 25 November 2026.

Consolidation Terms and Shareholder Impact

According to the filing, the consolidation is described as a mechanical adjustment to the number of shares on issue. The company disclosed that it does not, of itself, change Alcidion's market capitalisation, underlying value, assets, liabilities, cash position, strategy or operations. The consolidation also does not change a shareholder's proportional ownership interest, subject only to the treatment of fractional entitlements. Any fractional entitlement to a share or performance right arising from the consolidation will be rounded up to the nearest whole number. No action is required from shareholders, with shareholdings to be adjusted automatically on a 1-for-10 basis.

Consolidation Timetable and Trading Arrangements

The filing sets out a detailed timetable for the consolidation. The last day for trading pre-consolidation securities is 13 November 2026. Trading in reorganised securities on a deferred settlement basis is scheduled to commence on 16 November 2026, with the record date for the consolidation set at 17 November 2026. New holding statements reflecting post-consolidation holdings will begin to be issued from 18 November 2026. Deferred settlement trading is scheduled to end on 24 November 2026, with normal trading in reorganised securities commencing on 25 November 2026. The filing notes the timetable may be changed at the discretion of the board or as required by ASX.

Company Background and Operations

Alcidion Group Limited describes itself as a provider of software products and technical services for healthcare organisations. The company's flagship product is Miya Precision, which the filing states aggregates information to centralised dashboards, supports interoperability, facilitates communication and task management in clinical and operational settings, and delivers clinical decision support at the point of care. According to the filing, the company operates across three established markets — Australia, New Zealand and the United Kingdom — serving hospitals and healthcare organisations, with further geographical expansion stated as planned. The company has listed on the ASX since 2016.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.